Human cytomegalovirus UL69 protein is required for efficient accumulation of infected cells in the G1 phase of the cell cycle

Proceedings of the National Academy of Sciences of the United States of America

Volumn 97, Issue 6, 2000, Pages 2692-2696

  Hayashi, Mansuo Lu ^a,b   Blankenship, Catherine ^a   Shenk, Thomas ^a  

^a PRINCETON UNIVERSITY   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN DERIVATIVE;

ARTICLE; CELL CYCLE G1 PHASE; CONTROLLED STUDY; DNA CONTENT; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; MITOSIS INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; VIRUS CELL INTERACTION; VIRUS EXPRESSION; VIRUS PARTICLE; VIRUS REPLICATION;

CELL CYCLE; CELLS, CULTURED; CYTOMEGALOVIRUS; DNA REPLICATION; FIBROBLASTS; G1 PHASE; HUMANS; IMMEDIATE-EARLY PROTEINS; KINETICS; MUTATION; RNA, MESSENGER; TIME FACTORS; VIRAL PROTEINS;

CYTOMEGALOVIRUS; DNA VIRUSES; HUMAN HERPESVIRUS 5; UNIDENTIFIED RETROVIRUS;

EID: 0034646233     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.050587597     Document Type: Article

References (20)

1. Alfred, C. A., Stagno, S., Pass, R. F. & Britt, W. (1990) Rev. Infect. Dis. 12, S745-S753.
2. Britt, W. & Alfred, C. A. (1996) in Fields Virology, eds. Fields, B. N., Knipe, D. M. & Howley, P. M. (Lippincott-Raven, Philadelphia), pp. 2493-2523.
3. Jault, F. M., Jault, J. M., Ruchti, F., Fortunate, E. A., Clark, C., Corbeil, J., Richmann, D. D. & Spector, D. H. (1995) J. Virol. 69, 6697-6704.
4. Bresnahan, W. A., Boldogh, I., Thompson, E. A. & Albrecht, T. (1996) Virology 224, 150-160.
5. Lu, M. & Shenk, T. (1996) J. Virol. 70, 8850-8857.
6. Dittmer, D. & Mocarski, E. S. (1997) J. Virol. 71, 1629-1634.
7. Lu, M. & Shenk, T. (1999) J. Virol. 73, 676-683.A. J.
8. Winkler, M. & Stamminger, T. (1996) J. Virol. 70, 8984-8987.
9. Winkler, M., Rice, S. A. & Stamminger, T. (1994) J. Virol. 68, 3943-3954.
10. Romanowski, M., Garrido-Guerrero, E. & Shenk, T. (1997) J. Virol. 71, 5703-5705.
11. Plotkin, S. A., Furukawa, T., Zygraich, N. & Huygelen, C. (1975) Infect. Immun. 12, 521-527.
12. Chee, M. S., Bankier, A. T., Beck, S., Bohni, R., Brown, C. M., Cerny, R., Horsnell, T., Hutchison, C. A., III, Kouzarides, T., Martignetti, J. A., et al. (1990) Curr. Top. Microbiol. Immunol. 154, 125-170.
13. Baldick, C. J., Marchini, A., Patterson, C. E. & Shenk, T. (1997) J. Virol. 71, 4400-4408.
14. Kinsella, T. M. & Nolan, G. P. (1996) Hum. Gene Ther. 7, 1405-1413.
15. Patterson, C. E. & Shenk, T. (1999) J. Virol. 73, 7126-7131.
16. Stinski, M. F. (1976) J. Virol. 19, 594-609.
17. Wiebusch, L. & Hagemeier, C. (1999) J. Virol. 73, 9274-9283.
18. Pari, G. S. & Anders, D. G. (1993) J. Virol. 67, 6979-6988.
19. Iskenderian, A. C., Huang, L., Reilly, A., Stenberg, R. M. & Anders, D. G. (1996) J. Virol. 70, 383-392.
20. Sandri-Golden, R. M. (1998) Genes Dev. 12, 868-879.